A finished IHP 310 Module 7 post of roughly 350 words on fluid retention in heart failure, how pioglitazone and ibuprofen worsen it, guideline cautions and safer alternatives for diabetes and arthritis, closing with a question about who should catch the interaction. Searches like "ihp 310 module 7 assignment", "ihp310 module 7 comorbidity discussion" and "ihp 310 module 7 example" land here.
The IHP 310 Module 7 example, in full
Module Seven Discussion: Comorbidity and Drug Interactions
Re: Two prescriptions, one waterlogged heart
My example is Mr. Okafor, a composite 69-year-old retired electrician whose problem list reads: heart failure with a low ejection fraction, diabetes and osteoarthritis of both knees. He was admitted with swollen legs, a weight gain of 4 kilograms in a week and shortness of breath when lying flat. His medication list included pioglitazone, started two months earlier by a new endocrinologist, and ibuprofen 600 mg three times a day, bought over the counter for his knees.
In heart failure, the weakened heart pumps less blood forward. Sensing poor flow, the kidneys switch on hormonal systems, above all renin, angiotensin and aldosterone, that hold on to sodium and water in an attempt to restore volume. In a failing heart, that extra fluid backs up into the lungs and legs. Much of heart failure treatment works by blocking this response or removing the fluid with diuretics.
Both of his new drugs push the same way. Pioglitazone increases sodium and water reabsorption in the kidney's collecting ducts, expanding blood volume; pooled randomized trials show that drugs in its class raised the risk of heart failure events by about 70 percent compared with other treatments (Lago et al., 2007). Ibuprofen blocks the prostaglandins that help the kidney excrete sodium and keep blood flowing to the kidney, so salt is retained and his diuretic works less well (Page et al., 2016). Each drug on its own might have been tolerated; together they added fluid to a system already unable to handle it.
National heart failure guidance recommends avoiding thiazolidinediones and NSAIDs in patients with heart failure, and it supports sodium-glucose cotransporter 2 inhibitors, which lower glucose and reduce heart failure hospitalization (Heidenreich et al., 2022). A safer plan would stop pioglitazone and add an SGLT2 inhibitor, which treats both conditions, and replace ibuprofen with acetaminophen, topical diclofenac for the knee and physical therapy. My question for the group: Mr. Okafor had a cardiologist, an endocrinologist and a pharmacy, yet no one saw all three pieces. Whose job should it be to catch an interaction like this?
References
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18), e895-e1032. https://doi.org/10.1161/CIR.0000000000001063
Lago, R. M., Singh, P. P., & Nesto, R. W. (2007). Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: A meta-analysis of randomised clinical trials. The Lancet, 370(9593), 1129-1136. https://doi.org/10.1016/S0140-6736(07)61514-1
Page, R. L., II, O'Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. (2016). Drugs that may cause or exacerbate heart failure: A scientific statement from the American Heart Association. Circulation, 134(6), e32-e69. https://doi.org/10.1161/CIR.0000000000000426
How this IHP 310 Module 7 example is structured
The post is built around a shared mechanism. It opens with the admission. The second paragraph explains why the failing heart leads the kidneys to retain salt and water. The third shows how each drug adds to that retention by a different route. The fourth reports the guideline position and proposes alternatives for both comorbid conditions, and the post ends with a question about how different prescribers can see the whole picture.
Get IHP 310 Module 7 written to your instructions
Send your IHP 310 Module 7 discussion prompt and the rubric. A comorbidity post linking two conditions and two drug classes comes back within 24 to 48 hours; the first is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
IHP 310 Module 7 questions, answered
What does IHP 310 Module 7 usually ask?
A later discussion in this course often widens to comorbidity, asking how two disease processes interact and how the drugs used for one condition can affect another. Students may be asked to use an example patient and propose safer treatment choices.
Why can pioglitazone worsen heart failure?
Pioglitazone, a thiazolidinedione used for type 2 diabetes, increases sodium and water reabsorption in the kidney, which expands blood volume and can cause edema. In a person whose heart already struggles to handle fluid, this can precipitate heart failure symptoms.
Why are NSAIDs a concern in heart failure?
Nonsteroidal anti-inflammatory drugs block prostaglandins that help the kidney excrete sodium and maintain blood flow. The result is salt and water retention and reduced effect of diuretics, which can worsen heart failure and kidney function.